애브비(주)
DE ˙ XTRA ˙ US00287Y1091
€188.50 ↑0.35 (0.19%)
2026-06-04
주가
SecurityDE:4AB / AbbVie Inc.
InstitutionSWS Partners
Latest Disclosed Ownership123,002 shares
Latest Disclosed Value $ 2,675,112
SWS Partners reports 940.89% increase in ownership of 4AB / AbbVie Inc.

On April 21, 2026 - SWS Partners filed a 13F-HR form disclosing ownership of 123,002 shares of AbbVie Inc. (DE:4AB) valued at $22,804,571 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 11,817 shares of AbbVie Inc.. This represents a change in shares of 940.89% during the quarter. The current value of the position is $23,185,877 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F ABBVIE COM 00287Y109 123,002 111,185 940.89 2,675 -0.89 0.6598
2026-01-16 2025-12-31 13F ABBVIE COM 00287Y109 11,817 -1,180 -9.08 2,700 -10.30 0.6518
2025-10-16 2025-09-30 13F ABBVIE COM 00287Y109 12,997 420 3.34 3,009 28.92 0.7345
2025-07-17 2025-06-30 13F ABBVIE COM 00287Y109 12,577 -2,194 -14.85 2,335 -24.56 0.6299
2025-05-27 2025-03-31 13F/A-1 ABBVIE COM 00287Y109 14,771 327 2.26 3,095 20.58 1.0157
2025-05-19 2025-03-31 13F ABBVIE COM 00287Y109 14,443 -1 2,567 0.7772
2025-02-06 2024-12-31 13F ABBVIE COM 00287Y109 14,444 -35 -0.24 2,567 -10.25 0.7772
2024-10-15 2024-09-30 13F ABBVIE COM 00287Y109 14,479 -2,123 -12.79 2,859 0.53 0.9108
2024-07-17 2024-06-30 13F ABBVIE COM 00287Y109 16,602 356 2.19 2,844 -3.85 0.8502
2024-04-30 2024-03-31 13F Abbvie ABBV-US 00287Y109 16,246 -824 -4.83 2,958 11.83 0.8846
2024-02-13 2023-12-31 13F Abbvie ABBV-US 00287Y109 17,070 -318 -1.83 2,645 2.08 0.8622
2023-11-09 2023-09-30 13F Abbvie ABBV-US 00287Y109 17,388 -2,664 -13.29 2,592 -4.00 0.9581
2023-08-17 2023-06-30 13F/A-2 Abbvie COM 00287Y109 20,052 2,815 16.33 2,699 -1.75 0.9735
2023-07-26 2023-06-30 13F Abbvie COM 00287Y109 20,052 2,815 2,699 0.9684
2023-05-09 2023-03-31 13F Abbvie COM 00287Y109 17,237 -648 -3.62 2,747 137,250.00 1.0226
2023-01-30 2022-12-31 13F Abbvie COM 00287Y109 17,885 1,359 8.22 3 -99.91 1.3706
2022-11-09 2022-09-30 13F Abbvie COM 00287Y109 16,526 161 0.98 2,218 -11.53 1.0275
2022-07-28 2022-06-30 13F Abbvie COM 00287Y109 16,365 -2,028 -11.03 2,507 -16.01 2.1104
2022-05-05 2022-03-31 13F Abbvie COM 00287Y109 18,393 -2,008 -9.84 2,985 8.07 1.9523
2022-01-25 2021-12-31 13F Abbvie COM 00287Y109 20,401 -978 -4.57 2,762 19.77 1.5706
2021-11-08 2021-09-30 13F Abbvie COM 00287Y109 21,379 -12,430 -36.77 2,306 -39.44 1.4288
2021-08-09 2021-06-30 13F Abbvie COM 00287Y109 33,809 2,160 6.82 3,808 11.18 2.4782
2021-05-17 2021-03-31 13F Abbvie COM 00287Y109 31,649 3,832 13.78 3,425 14.89 2.3571
2021-03-31 2020-12-31 13F Abbvie COM 00287Y109 27,817 790 2.92 2,981 25.94 1.3284
2020-11-13 2020-09-30 13F Abbvie COM 00287Y109 27,027 9,932 58.10 2,367 45.84 1.1858
2020-08-13 2020-06-30 13F ABBVIE COM 00287Y109 17,095 -2,822 -14.17 1,623 6.92 2.0666
2020-05-14 2020-03-31 13F ABBVIE COM 00287Y109 19,917 -7,384 -27.05 1,518 -15.95 1.0851
2019-11-15 2019-09-30 13F ABBVIE COM 00287Y109 27,301 27,301 1,806 0.0657
2019-08-13 2019-06-30 13F ABBVIE COM 00287Y109 0 -19,934 -100.00 0 -100.00
2019-02-04 2018-12-31 13F ABBVIE COM 00287Y109 19,934 -7,179 -26.48 1,838 -28.34 1.3928
2018-11-14 2018-09-30 13F ABBVIE COM 00287Y109 27,113 5,588 25.96 2,565 28.64 1.6284
2018-08-13 2018-06-30 13F ABBVIE COM 00287Y109 21,525 2,658 14.09 1,994 15.53 1.4014
2018-05-15 2018-03-31 13F ABBVIE COM 00287Y109 18,867 295 1.59 1,726 -3.90 1.2713
2018-02-15 2017-12-31 13F ABBVIE COM 00287Y109 18,572 18,572 1,796 1.3497
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.